About Changing the RA Narrative

About-Hero_0

An international initiative aimed at elevating the important role of the person living with RA

Changing the RA NarRAtive is an international initiative aimed at elevating the important role of the patient in the management of RA. Supported by Pfizer, the RA NarRAtive initiative is directed by a global Advisory Panel comprised of 39 healthcare providers and patient support group leaders from 17 countries. The purpose of Changing the RA NarRAtive is to create positive change within the RA community by harnessing the experience of people living with RA, physicians and patient advocates, to develop resources that break down communication barriers and change expectations to improve RA disease management.

The RA NarRAtive gathered insights from physicians and patient perspectives in the management of RA through two global surveys fielded to almost 4,000 adults with RA and nearly 1,700 physicians.

In reviewing and discussing the findings of both surveys, the Advisory Panel suggests that people with RA and healthcare providers can establish a new narrative, a new conversation around RA by recognizing the unique important perspective of each.

The RA Narrative Weighted Survey Methodology

The RA NarRAtive Patient Survey

The RA Narrative patient survey was conducted online by Harris Poll on behalf of Pfizer between September 4 and December 24, 2014, January 9-13, 2015 and September 3, 2015 and January 13, 2016 among 3987 adults ages 18+ who have been diagnosed with rheumatoid arthritis (RA) in the U.S. (n=526), Canada (n=237), Brazil (n=324), Argentina (n=217), Australia (n=481), South Korea (n=224), Japan (n=354), Germany (n=525), France (n=122), Spain (n=122), the UK (n=246), Italy (n=204), Turkey (n=123), Hong Kong (n=192), and Taiwan (n=90).

Raw data were weighted where necessary to reflect the general adult (or online adult) population in each country (sample sizes noted above). For the global, 15-country total, a post-weight was applied to adjust for the relative size of each country’s adult population within the total adult population across all countries surveyed. The unweighted sample sizes above reflect the total number of patients who completed the survey in each country, while all reported percentages are calculated based on the weighted global total described here.

The RA Narrative Physician

The RA Narrative physician survey was conducted online by Harris Poll on behalf of Pfizer between August 14 and October 2, 2015 among 1666 rheumatologists ages 18+ who have seen at least five (5) RA patients in the past month whose RA is moderately to severely active or severely active in the U.S. (n=208), Canada (n=50), Brazil (n=150), Argentina (n=130), Australia (n=60*), South Korea (n=100), Japan (n=139), Germany (n=150), France (n=149), Spain (n=100), the UK (n=150), Italy (n=100), Turkey (n=50*), Hong Kong (n=30), and Taiwan (n=100).

Physician results in the U.S. were weighted by region and years in practice by gender. In all other countries, raw data were not weighted at the individual country level (sample sizes noted above), and therefore are only representative of the individuals who completed the survey. For the global, 15-country total, a post-weight was applied to adjust for the relative size of each country’s adult population within the total adult population across all countries surveyed. The unweighted sample sizes above reflect the total number of HCPs who completed the survey in each country, while all reported percentages are calculated based on the weighted global total described here.